Quest Diagnostics' H1N1 Flu PCR Test Gets FDA Clearance

Simplexa, manufactured by Quest's Focus Diagnostics business, is the first test to be cleared by the FDA to aid in detecting and differentiating influenza A and 2008 H1N1 influenza viral RNA.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.